Published in Transgenic Res on March 01, 1996
Dystrophin contains multiple independent membrane-binding domains. Hum Mol Genet (2016) 0.75
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol (2000) 6.33
Evaluation of the Repliscan system for identification of Enterobacteriaceae. J Clin Microbiol (1978) 5.07
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome (1997) 4.15
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrob Agents Chemother (1996) 3.82
A type VII myosin encoded by the mouse deafness gene shaker-1. Nature (1995) 3.71
Helpers: effects of experimental removal on reproductive success. Science (1982) 3.70
A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat (2011) 3.40
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol (2008) 2.95
Percutaneous laser thermal angioplasty: initial results and 1-year follow-up in 129 femoropopliteal lesions. Radiology (1988) 2.90
Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet (1997) 2.88
Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J Clin Microbiol (1996) 2.70
Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression. Mol Cell Biol (2000) 2.56
Sequence interpretation. Functional annotation of mouse genome sequences. Science (2001) 2.54
Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology (1995) 2.47
Myosin VIIa participates in opsin transport through the photoreceptor cilium. J Neurosci (1999) 2.44
Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet (1997) 2.40
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother (2002) 2.33
Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development (1998) 2.23
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 2.14
Organization and evolutionary progress of a dispersed repetitive family of sequences in widely separated rodent genomes. J Mol Biol (1981) 2.10
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99
Cloning of a novel member of the low-density lipoprotein receptor family. Gene (1998) 1.97
Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagn Microbiol Infect Dis (2000) 1.82
Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin. J Antimicrob Chemother (1997) 1.79
Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions. Lancet (1986) 1.72
Evaluation of gastrointestinal bleeding by red blood cells labeled in vivo with technetium-99m. J Nucl Med (1979) 1.69
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Antimicrob Agents Chemother (1998) 1.67
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob Agents Chemother (1998) 1.63
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59
Microdissection of and microcloning from the short arm of human chromosome 2. Mol Cell Biol (1986) 1.55
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 1.45
DNA topoisomerase I is essential in Drosophila melanogaster. Proc Natl Acad Sci U S A (1993) 1.44
Survival differences between black and white women with breast cancer. J Surg Oncol (1994) 1.44
In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests. J Antimicrob Chemother (1999) 1.43
Loss of heterozygosity and microsatellite instability at the MLL locus are common in childhood acute leukemia, but not in infant acute leukemia. Blood (1999) 1.42
A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet (1999) 1.42
A comparative study on the in vivo behavior of hydroxyapatite and silicon substituted hydroxyapatite granules. J Mater Sci Mater Med (2002) 1.42
Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet (1998) 1.36
Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells. J Neurosci (1997) 1.36
High-performance liquid-chromatographic assay of aminoglycoside antibiotics in serum. Clin Chem (1978) 1.34
Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics (1993) 1.34
Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia (2000) 1.32
Genetics of deafness. Curr Opin Neurobiol (1996) 1.28
The mouse slalom mutant demonstrates a role for Jagged1 in neuroepithelial patterning in the organ of Corti. Hum Mol Genet (2001) 1.28
The kyphoscoliosis (ky) mouse is deficient in hypertrophic responses and is caused by a mutation in a novel muscle-specific protein. Hum Mol Genet (2001) 1.27
Radionuclide localization of lower gastrointestinal hemorrhage. Radiology (1981) 1.26
The murine polycomb-group genes Ezh1 and Ezh2 map close to Hox gene clusters on mouse chromosomes 11 and 6. Mamm Genome (1999) 1.26
Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Chemother (1997) 1.25
Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res (1997) 1.24
Effects of shaker-1 mutations on myosin-VIIa protein and mRNA expression. Cell Motil Cytoskeleton (1997) 1.24
In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients. Antimicrob Agents Chemother (2006) 1.24
Construction of a mouse yeast artificial chromosome library in a recombination-deficient strain of yeast. Nat Genet (1992) 1.23
Beta-adrenergic blocking activity of Yersinia pestis murine toxin. Infect Immun (1977) 1.22
Perceptual organization of acoustic stimuli by budgerigars (Melopsittacus undulatus): I. Pure tones. J Comp Psychol (1987) 1.22
A YAC-based physical map of the mouse genome. Nat Genet (1999) 1.22
Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm Genome (1996) 1.20
A prospective and blinded investigation of magnetic resonance imaging of the knee. Abnormal findings in asymptomatic subjects. Clin Orthop Relat Res (1992) 1.20
Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes. J Histochem Cytochem (2000) 1.20
Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement events. Mol Cell Biol (1991) 1.19
Large numbers of mice established by in vitro fertilization with cryopreserved spermatozoa: implications and applications for genetic resource banks, mutagenesis screens, and mouse backcrosses. Mamm Genome (1999) 1.19
Mutation analysis of the mouse myosin VIIA deafness gene. Genes Funct (1997) 1.19
The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase. Nat Genet (1999) 1.18
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. Eur J Clin Microbiol Infect Dis (1997) 1.17
In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers. Antimicrob Agents Chemother (1998) 1.17
Angiodysplasia of the colon: a cause of rectal bleeding. Cardiovasc Radiol (1979) 1.16
Permanent Genetic Resources added to Molecular Ecology Resources Database 1 May 2009-31 July 2009. Mol Ecol Resour (2009) 1.15
Mutations in connexin31 underlie recessive as well as dominant non-syndromic hearing loss. Hum Mol Genet (2000) 1.15
A high-resolution microsatellite map of the mouse genome. Genome Res (1998) 1.14
In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents. Antimicrob Agents Chemother (1996) 1.14
Comparative genome sequence analysis of the Bpa/Str region in mouse and Man. Genome Res (2000) 1.13
Intraoperative localization of small bowel bleeding sites with combined use of angiographic methods and methylene blue injection. Surgery (1980) 1.13
The specific organisation of satellite DNA sequences on the X-chromosome of Mus musculus: partial independence of chromosome evolution. Nucleic Acids Res (1980) 1.13
Myosin VIIA gene: heterogeneity of the mutations responsible for Usher syndrome type IB. Hum Mol Genet (1997) 1.13
Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource. Mamm Genome (2000) 1.11
Criteria for testing the susceptibility of Streptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 microgram or 30 micrograms cefotaxime disks. Eur J Clin Microbiol Infect Dis (1995) 1.11
The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13. Genomics (2001) 1.11
Discrimination of synthetic full-formant and sinewave/ra-la/continua by budgerigars (Melopsittacus undulatus) and zebra finches (Taeniopygia guttata). J Acoust Soc Am (1995) 1.08
A prospective randomized study of sutured versus stapled bowel anastomoses in patients with cancer. Cancer (1986) 1.08
The clinical course of patients with suspected pulmonary embolism and a negative pulmonary arteriogram. Radiology (1978) 1.07
The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome. Nature (1987) 1.06
Insertion sequences and tandem repetitions as sources of variation in a dispersed repeat family. J Mol Biol (1983) 1.06
In vitro antimicrobial activity of MSI-78, a magainin analog. Antimicrob Agents Chemother (1998) 1.05
The bio operon on the acquired symbiosis island of Mesorhizobium sp. strain R7A includes a novel gene involved in pimeloyl-CoA synthesis. Microbiology (2001) 1.05
Asbestos and silica-induced changes in human alveolar macrophage phenotype. Environ Health Perspect (1997) 1.04
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator. Antimicrob Agents Chemother (2000) 1.03
Transcatheter vessel occlusion: selection of methods and materials. Cardiovasc Intervent Radiol (1980) 1.03
Human percutaneous and intraoperative laser thermal angioplasty: initial clinical results as an adjunct to balloon angioplasty. J Vasc Surg (1987) 1.02
In vitro activities of three nonfluorinated quinolones against representative bacterial isolates. Antimicrob Agents Chemother (2001) 1.01
In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob Agents Chemother (1995) 1.01
Perceptual organization of acoustic stimuli by budgerigars (Melopsittacus undulatus): II. Vocal signals. J Comp Psychol (1987) 1.00
Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media. Antimicrob Agents Chemother (2001) 1.00
Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests. J Antimicrob Chemother (1997) 0.99
Microdissection and microcloning of the mouse X chromosome. Proc Natl Acad Sci U S A (1985) 0.99
Informatics for mutagenesis: the design of mutabase--a distributed data recording system for animal husbandry, mutagenesis, and phenotypic analysis. Mamm Genome (2000) 0.99
Urban particle-induced apoptosis and phenotype shifts in human alveolar macrophages. Environ Health Perspect (1998) 0.98
Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. J Clin Microbiol (2001) 0.98
Speech perception by budgerigars (Melopsittacus undulatus): spoken vowels. Percept Psychophys (1990) 0.98
Auditory perception of conspecific and heterospecific vocalizations in birds: evidence for special processes. J Comp Psychol (1992) 0.97